ATE382696T1 - Immunoreaktive antigene des hepatitis e viruses - Google Patents

Immunoreaktive antigene des hepatitis e viruses

Info

Publication number
ATE382696T1
ATE382696T1 AT94928211T AT94928211T ATE382696T1 AT E382696 T1 ATE382696 T1 AT E382696T1 AT 94928211 T AT94928211 T AT 94928211T AT 94928211 T AT94928211 T AT 94928211T AT E382696 T1 ATE382696 T1 AT E382696T1
Authority
AT
Austria
Prior art keywords
hepatitis
virus
viruse
molecules
immunoreactive antigens
Prior art date
Application number
AT94928211T
Other languages
English (en)
Inventor
David Andrew Anderson
Stephen Alistair Locarnini
Joseph Torresi
Fan Li
Zhuang Hui
Original Assignee
Macfarlane Burnet Inst For Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPM2964A external-priority patent/AUPM296493A0/en
Application filed by Macfarlane Burnet Inst For Med filed Critical Macfarlane Burnet Inst For Med
Application granted granted Critical
Publication of ATE382696T1 publication Critical patent/ATE382696T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94928211T 1993-09-24 1994-09-23 Immunoreaktive antigene des hepatitis e viruses ATE382696T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM142393 1993-09-24
AUPM2964A AUPM296493A0 (en) 1993-12-15 1993-12-15 Immunoreactive antigens of hepatitis e virus - II

Publications (1)

Publication Number Publication Date
ATE382696T1 true ATE382696T1 (de) 2008-01-15

Family

ID=25644547

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928211T ATE382696T1 (de) 1993-09-24 1994-09-23 Immunoreaktive antigene des hepatitis e viruses

Country Status (9)

Country Link
US (1) US6514690B1 (de)
EP (1) EP0722499B1 (de)
JP (1) JPH09503912A (de)
AT (1) ATE382696T1 (de)
AU (1) AU694139B2 (de)
CA (1) CA2170521A1 (de)
DE (1) DE69435059D1 (de)
SG (1) SG95574A1 (de)
WO (1) WO1995008632A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214970B1 (en) 1988-06-17 2001-04-10 Genelabs Technologies, Inc. Hepatitis E virus antigens and uses therefor
US6787145B1 (en) 1992-09-18 2004-09-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
US6207416B1 (en) 1992-09-18 2001-03-27 The United States Of America As Represented By The Department Of Health And Human Services Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
DE69334299D1 (de) 1992-09-18 2009-12-31 Us Gov Health & Human Serv Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
AU694139B2 (en) * 1993-09-24 1998-07-16 Macfarlane Burnet Centre For Medical Research Limited, The Immunoreactive antigens of hepatitis E virus
US6054567A (en) * 1997-04-11 2000-04-25 The United States Of America As Represented By The Department Of Health And Human Services Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
US6458562B1 (en) 1998-04-09 2002-10-01 The United States Of America As Represented By The Secretary Of Health And Human Services Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
CA2283538A1 (en) * 1999-09-30 2001-03-30 Mun Hon Ng New hev antigenic peptide and methods
US7786264B2 (en) * 2001-11-08 2010-08-31 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
FR3044312B1 (fr) 2015-11-30 2017-12-08 Biomerieux Sa Polypeptides mutes de hev et leur utilisation pour le dosage d'anticorps anti-hev
US10883980B2 (en) * 2016-09-22 2021-01-05 The Trustees Of Princeton University Methods and compositions for inhibiting hepatitis E virus
ES2986329T3 (es) * 2017-01-30 2024-11-11 Institut Nat De La Sante Et De Larecherche Medicale Inserm Polipéptidos de la cápside de ORF2 del virus de la hepatitis E y usos de los mismos
CN106939034B (zh) * 2017-03-22 2021-03-30 中国食品药品检定研究院 用于鉴定受试者所感染的hev基因型的方法和试剂盒
US20210269510A1 (en) * 2018-07-10 2021-09-02 Inserm (Institut National De La Santè Et De La Recherch Médicale Antibodies having specificity for the orf2i protein of hepatitis e virus and uses thereof for diagnostic purposes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885768A (en) * 1988-06-17 1999-03-23 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis E virus peptide antigen and antibodies
US6455492B1 (en) * 1988-06-17 2002-09-24 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5741490A (en) * 1988-06-17 1998-04-21 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
DE69334299D1 (de) * 1992-09-18 2009-12-31 Us Gov Health & Human Serv Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
AU694139B2 (en) * 1993-09-24 1998-07-16 Macfarlane Burnet Centre For Medical Research Limited, The Immunoreactive antigens of hepatitis E virus

Also Published As

Publication number Publication date
CA2170521A1 (en) 1995-03-30
JPH09503912A (ja) 1997-04-22
US6514690B1 (en) 2003-02-04
SG95574A1 (en) 2003-04-23
AU694139B2 (en) 1998-07-16
WO1995008632A1 (en) 1995-03-30
EP0722499A1 (de) 1996-07-24
AU7734894A (en) 1995-04-10
EP0722499A4 (de) 2000-12-27
EP0722499B1 (de) 2008-01-02
DE69435059D1 (de) 2008-02-14

Similar Documents

Publication Publication Date Title
FI935808A0 (fi) Hepatit-C-virus (HCV) polypeptider
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
EA200100619A1 (ru) Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов
DE69030124D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
ATE130765T1 (de) Gentechnologisch veränderte immunglobuline.
ATE109795T1 (de) Htlv-iii umhüllende peptiden.
NO924780L (no) Ekspresjon av spesifikke immunogener ved bruk av virusantigener
DE69232906T2 (de) Detektion des Hepatis-C Virus.
IL138586A0 (en) Epitopes in viral envelope proteins and specific antibodies directed against these epitopes and use for detection of hcv viral antigen in host tissue
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
EP0967223A3 (de) Hepatitis C Virus Peptidantigene und Verfahren zur Bestimung von Hepatitis C Virus (HCV)
DE69928064D1 (de) Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen
WO1995032290A3 (en) Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
Dueñas‐Carrera et al. Immunological evaluation of Escherichia coli‐derived hepatitis C virus second envelope protein (E2) variants
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
BR0204599A (pt) Sequências de proteìna de núcleo de hcv
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties